SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marianne Canonico, Geneviève Plu-Bureau, Mary Jo O’Sullivan, Marcia L. Stefanick, Barbara Cochrane, Pierre-Yves Scarabin, JoAnn E. Manson, Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women, Menopause, 2014, 21, 3, 214

    CrossRef

  2. 2
    Andrew Eisenberger, Carolyn Westhoff, Hormone replacement therapy and venous thromboembolism, The Journal of Steroid Biochemistry and Molecular Biology, 2014, 142, 76

    CrossRef

  3. 3
    Amos Pines, CLIMACTERIC COMMENTARIES, Climacteric, 2013, 16, 6, 718

    CrossRef

  4. 4
    Annica Bergendal, Katarina Bremme, Karin Hedenmalm, Gerd Lärfars, Jacob Odeberg, Ingemar Persson, Anders Sundström, Helle Kieler, Risk factors for venous thromboembolism in pre-and postmenopausal women, Thrombosis Research, 2012, 130, 4, 596

    CrossRef

  5. 5
    S. SWEETLAND, V. BERAL, A. BALKWILL, B. LIU, V. S. BENSON, M. CANONICO, J. GREEN, G. K. REEVES, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, Journal of Thrombosis and Haemostasis, 2012, 10, 11
  6. 6
    Florence Tremollieres, Marc Brincat, C. Tamer Erel, Marco Gambacciani, Irene Lambrinoudaki, Mette H. Moen, Karin Schenck-Gustafsson, Svetlana Vujovic, Serge Rozenberg, Margaret Rees, EMAS position statement: Managing menopausal women with a personal or family history of VTE, Maturitas, 2011, 69, 2, 195

    CrossRef

  7. 7
    Valérie Olié, Marianne Canonico, Pierre-Yves Scarabin, Postmenopausal hormone therapy and venous thromboembolism, Thrombosis Research, 2011, 127, S26

    CrossRef

  8. 8
    Valérie Olié, Marianne Canonico, Pierre-Yves Scarabin, Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women, Current Opinion in Hematology, 2010, 17, 5, 457

    CrossRef